ERBB2 and prostate cancer: To date, vaccines against pancreatic cancer (telomerase peptides) [22], lung cancer (MUC1) [23], breast cancer (HER2) [24], and prostate cancer (prostatic acid phosphatase, PAP) [25] have been tested clinically.